Measurement of the minimum apparent diffusion coefficient (ADCmin) of the primary tumor and CA125 are predictive of disease recurrence for patients with endometrial cancer

Gynecologic Oncology

Volumn 124, Issue 2, 2012, Pages 335-339

  Nakamura, Keiichiro ^a   Imafuku, Noriaki ^a   Nishida, Takeshi ^a   Niwa, Ieyasu ^a   Joja, Ikuo ^b   Hongo, Atsushi ^a   Kodama, Junichi ^a   Hiramatsu, Yuji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Endometrial cancer; Magnetic resonance imaging; Recurrence; Serum CA125; The minimum apparent diffusion coefficient

Indexed keywords

CA 125 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; CYTOLOGY; DISEASE FREE SURVIVAL; ENDOMETRIUM CANCER; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MYOMETRIUM; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY METASTASIS; PERITONEUM; PREDICTION; PREOPERATIVE EVALUATION; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; TUMOR VOLUME; UTERINE CERVIX;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CA-125 ANTIGEN; CARBOPLATIN; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PACLITAXEL; PREDICTIVE VALUE OF TESTS;

EID: 84856019166     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.10.014     Document Type: Article

References (32)

1. R. Siegel, E. Ward, O. Brawley, and A. Jemal Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths CA Cancer J Clin 61 2011 212 236
2. Annual report of Oncology Committee of Japan Society of Obstetrics and Gynecology, Tokyo, Japan 2011
3. C.P. Morrow, B.N. Bundy, R.J. Kurman, W.T. Creasman, P. Heller, and H.D. Homesley Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study Gynecol Oncol 40 1991 55 65
4. J.G. Aalders, V. Abeler, and P. Kolstad Recurrent adenocarcinoma of the endometrium: a clinical and histopathological study of 379 patients Gynecol Oncol 17 1984 85 103 (Pubitemid 14176295)
5. M.L. Berman, S.C. Ballon, L.D. Lagasse, and W.G. Watring Prognosis and treatment of endometrial cancer Am J Obstet Gynecol 136 1980 679 688 (Pubitemid 10156234)
6. R.C. Boronow, C.P. Morrow, W.T. Creasman, P.J. Disaia, S.G. Silverberg, and A. Miller Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study Obstet Gynecol 63 1984 825 832 (Pubitemid 14105231)
7. W.T. Creasman, C.P. Morrow, B.N. Bundy, H.D. Homesley, J.E. Graham, and P.B. Heller Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group study Cancer 60 1987 2035 2041 (Pubitemid 17145924)
8. D. Gal, F.O. Recio, D. Zamurovic, and M.L. Tancer Lymphvascular space involvement-a prognostic indicator in endometrial adenocarcinoma Gynecol Oncol 42 1991 142 145
9. D.M. Larson, G.P. Connor, S.K. Broste, B.R. Krawisz, and K.K. Johnson Prognostic significance of gross myometrial invasion with endometrial cancer Obstet Gynecol 88 1996 394 398 (Pubitemid 26293285)
10. H.S. Kim, N.H. Park, H.H. Chung, J.W. Kim, Y.S. Song, and S.B. Kang Serum CA-125 level after 6 cycles of primary adjuvant chemotherapy is a useful prognostic factor for complete responders' survival in patients with advanced epithelial ovarian cancer Onkologie 31 2008 315 320 (Pubitemid 351839731)
11. P.G. Rose, R.M. Sommers, F.R. Reale, R.E. Hunter, L. Farnier, and B.E. Nelson Serial serum CA 125 measurements for evaluation of recurrence in patients with endometrial carcinoma Obstet Gynecol 84 1994 12 16 (Pubitemid 24202948)
12. J.M. Duk, J.G. Aalders, G.J. Fleuren, and H.W. de Bruijn CA 125: a useful marker in endometrial carcinoma Am J Obstet Gynecol 155 1986 1097 1102 (Pubitemid 17176689)
13. J.M. Duk, J.G. Aalders, G.J. Fleuren, M. Krans, and H.W. De Bruijn Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix Obstet Gynecol 73 1989 661 668 (Pubitemid 19086983)
14. O. Dudeck, M. Zeile, D. Pink, M. Pech, P.U. Tunn, and P. Reichardt Diffusion-weighted magnetic resonance imaging allows monitoring of anticancer treatment effects in patients with soft-tissue sarcomas J Magn Reson Imaging 27 2008 1109 1113 (Pubitemid 351614624)
15. A.C. Guo, T.J. Cummings, R.C. Dash, and J.M. Provenzale Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics Radiology 224 2002 177 183 (Pubitemid 34680392)
16. B. Taouli, V. Vilgrain, E. Dumont, J.L. Daire, B. Fan, and Y. Menu Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients Radiology 226 2003 71 78 (Pubitemid 36163910)
17. J. Zhang, Y.M. Tehrani, L. Wang, N.M. Ishill, L.H. Schwartz, and H. Hricak Renal masses: characterization with diffusion-weighted MR imaging-a preliminary experience Radiology 247 2008 458 464
18. Y. Hayashida, T. Hirai, S. Morishita, M. Kitajima, R. Murakami, and Y. Korogi Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity AJNR Am J Neuroradiol 27 2006 1419 1425 (Pubitemid 44260120)
19. N. Kanauchi, H. Oizumi, T. Honma, H. Kato, M. Endo, and J. Suzuki Role of diffusion-weighted magnetic resonance imaging for predicting of tumor invasiveness for clinical stage IA non-small cell lung cancer Eur J Cardiothorac Surg 35 2009 706 710
20. B. Taouli, R.K. Thakur, L. Mannelli, J.S. Babb, S. Kim, and E.M. Hecht Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging Radiology 251 2009 398 407
21. D.M. Koh, and D.J. Collins Diffusion-weighted MRI in the body: applications and challenges in oncology AJR Am J Roentgenol 188 2007 1622 1635 (Pubitemid 46866868)
22. U. Sharma, K.K. Danishad, V. Seenu, and N.R. Jagannathan Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy NMR Biomed 22 2009 104 113
23. K. Tamai, T. Koyama, T. Saga, S. Umeoka, Y. Mikami, and S. Fujii Diffusion-weighted MR imaging of uterine endometrial cancer J Magn Reson Imaging 26 2007 682 687 (Pubitemid 350194592)
24. C.S. Whittaker, A. Coady, L. Culver, G. Rustin, M. Padwick, and A.R. Padhami Diffusion-weighted MR imaging of female pelvic tumors: a pictorial review Radiographics 29 2009 759 774
25. G. Lin, K.K. Ng, C.J. Chang, J.J. Wang, HOKC, and T.C. Ten Myometrial invasion in endometrial cancer: diagnostic accuracy of diffusion-weighted 3.0-T MR imaging-initial experience Radiology 250 2009 784 792
26. J.M. Provenzale, S. Mukundan, and D.P. Barboriak Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response Radiology 239 2006 632 649 (Pubitemid 43830599)
27. N. Matsushima, M. Maeda, M. Takamura, and K. Takeda Apparent diffusion coefficients of benign and malignant salivary gland tumors. Comparison to histopathological findings J Neuroradiol 34 2007 183 189 (Pubitemid 47042899)
28. A.A. Abdel Razek, N.Y. Soliman, S. Elkhamary, S. Elkhamary, M.K. Alsharaway, and A. Tawfik Role of diffusion-weighted MR imaging in cervical lymphadenopathy Eur Radiol 16 2006 1468 1477 (Pubitemid 43871818)
29. P.D. Humphries, N.J. Sebire, M.J. Siegel, and ∅.E. Olsen Tumors in pediatric patients at diffusion-weighted MR imaging: apparent diffusion coefficient and tumor cellularity Radiology 245 2007 848 854 (Pubitemid 350127356)
30. N. Takeshima, Y. Shimizu, S. Umezawa, Y. Hirai, J.T. Chen, and I. Fujimoto Combined assay of serum levels of CA125 and CA19-9 in endometrial carcinoma Gynecol Oncol 54 1994 321 326 (Pubitemid 24301907)
31. A.K. Sood, R.E. Buller, R.A. Burger, J.D. Dawson, J.I. Sorosky, and M. Berman Value of preoperative CA 125 level in the management of uterine cancer and prediction of clinical outcome Obstet Gynecol 90 1997 441 447 (Pubitemid 27357939)
32. J.T. Soper, A. Berchuck, G.J. Olt, A.P. Soisson, D.J. Clarke-Pearson, and R.L. Bast Jr. Preoperative evaluation of serum CA 125, TAG 72, and CA 15-3 in patients with endometrial carcinoma Am J Obstet Gynecol 163 1990 1204 1209 (Pubitemid 20377403)